This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brinkmann, U Articles by Pastan, I Search for Related Content PubMed PubMed Citation Articles by Brinkmann, U Articles by Pastan, I Social Bookmarking                   What's this?

The human CAS (cellular apoptosis susceptibility) gene mapping on chromosome 20q13 is amplified in BT474 breast cancer cells and part of aberrant chromosomes in breast and colon cancer cell lines.

Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-4255, USA.

Abstract

The CAS (cellular apoptosis susceptibility) gene is the human homolog of the yeast chromosome segregation gene CSE1. CAS may have a dual function in mammalian cells, one in apoptosis and another in cell proliferation. We have now mapped the CAS gene to chromosome 20q13. This region is known to harbor amplifications that correlate with aggressive breast cancer. Southern hybridizations with a CAS cDNA fragment and fluorescent in situ hybridization (FISH) with a P1 clone containing the CAS gene show elevated copy numbers in one leukemia, three of four colon, and in three of seven breast cancer cell lines. Elevated CAS copy number in CEM leukemia and COLO201 colon cancer cells was attributable to additional copies of chromosome 20. In SW480 and COLO205 colon cancer cells CAS is part of aberrant chromosomes containing large parts of 20q. In breast cancer cells CAS is also part of aberrant 20q chromosomes (MDA-MB-157 and UACC-812) or of additional 20q isochromosome in MDA-MB-134. In MDA-MB361 and BT-474 breast cancer cells CAS is separated from other markers centromeric and telomeric of CAS on 20q. MDA-MB 361 contains one additional copy of CAS, separated from the centromeric 20q control probe. BT-474 cells have up to 12 additional CAS copies that we separated from nearby telomeric and centromeric probes on 20q and that are translocated to abnormal chromosomes.

CiteULike

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				C. Ginestier, N. Cervera, P. Finetti, S. Esteyries, B. Esterni, J. Adelaide, L. Xerri, P. Viens, J. Jacquemier, E. Charafe-Jauffret, et al. Prognosis and Gene Expression Profiling of 20q13-Amplified Breast Cancers Clin. Cancer Res., August 1, 2006; 12(15): 4533 - 4544. [Abstract] [Full Text] [PDF]

				P. L. Andersen, H. Zhou, L. Pastushok, T. Moraes, S. McKenna, B. Ziola, M. J. Ellison, V. M. Dixit, and W. Xiao Distinct regulation of Ubc13 functions by the two ubiquitin-conjugating enzyme variants Mms2 and Uev1A J. Cell Biol., August 29, 2005; 170(5): 745 - 755. [Abstract] [Full Text] [PDF]

				J. M. Lage, J. H. Leamon, T. Pejovic, S. Hamann, M. Lacey, D. Dillon, R. Segraves, B. Vossbrinck, A. Gonzalez, D. Pinkel, et al. Whole Genome Analysis of Genetic Alterations in Small DNA Samples Using Hyperbranched Strand Displacement Amplification and Array-CGH Genome Res., February 1, 2003; 13(2): 294 - 307. [Abstract] [Full Text] [PDF]

				A. Bar-Shira, J. H. Pinthus, U. Rozovsky, M. Goldstein, W. R. Sellers, Y. Yaron, Z. Eshhar, and A. Orr-Urtreger Multiple Genes in Human 20q13 Chromosomal Region Are Involved in an Advanced Prostate Cancer Xenograft Cancer Res., December 1, 2002; 62(23): 6803 - 6807. [Abstract] [Full Text] [PDF]

				S. Sen, H. Zhou, R.-D. Zhang, D. S. Yoon, F. Vakar-Lopez, S. Ito, F. Jiang, D. Johnston, H. B. Grossman, A. C. Ruifrok, et al. Amplification/Overexpression of a Mitotic Kinase Gene in Human Bladder Cancer J Natl Cancer Inst, September 4, 2002; 94(17): 1320 - 1329. [Abstract] [Full Text] [PDF]

				J. M. Hernandez, J. L. Garcia, N. C. Gutierrez, M. Mollejo, J. A. Martinez-Climent, T. Flores, M. B. Gonzalez, M. A. Piris, and J. F. San Miguel Novel Genomic Imbalances in B-Cell Splenic Marginal Zone Lymphomas Revealed by Comparative Genomic Hybridization and Cytogenetics Am. J. Pathol., May 1, 2001; 158(5): 1843 - 1850. [Abstract] [Full Text] [PDF]

				O. Monni, M. Bärlund, S. Mousses, J. Kononen, G. Sauter, M. Heiskanen, P. Paavola, K. Avela, Y. Chen, M. L. Bittner, et al. Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer PNAS, April 25, 2001; (2001) 91582298. [Abstract] [Full Text]

				M. Barlund, F. Forozan, J. Kononen, L. Bubendorf, Y. Chen, M. L. Bittner, J. Torhorst, P. Haas, C. Bucher, G. Sauter, et al. Detecting Activation of Ribosomal Protein S6 Kinase by Complementary DNA and Tissue Microarray Analysis J Natl Cancer Inst, August 2, 2000; 92(15): 1252 - 1259. [Abstract] [Full Text] [PDF]

				F. Forozan, E. H. Mahlamäki, O. Monni, Y. Chen, R. Veldman, Y. Jiang, G. C. Gooden, S. P. Ethier, A. Kallioniemi, and O.-P. Kallioniemi Comparative Genomic Hybridization Analysis of 38 Breast Cancer Cell Lines: A Basis for Interpreting Complementary DNA Microarray Data Cancer Res., August 1, 2000; 60(16): 4519 - 4525. [Abstract] [Full Text]

				W.'e. El-Rifai, M. Sarlomo-Rikala, L. C. Andersson, S. Knuutila, and M. Miettinen DNA Sequence Copy Number Changes in Gastrointestinal Stromal Tumors: Tumor Progression and Prognostic Significance Cancer Res., July 1, 2000; 60(14): 3899 - 3903. [Abstract] [Full Text]

				S. Hidaka, T. Yasutake, H. Takeshita, M. Kondo, T. Tsuji, A. Nanashima, T. Sawai, H. Yamaguchi, T. Nakagoe, H. Ayabe, et al. Differences in 20q13.2 Copy Number between Colorectal Cancers with and without Liver Metastasis Clin. Cancer Res., July 1, 2000; 6(7): 2712 - 2717. [Abstract] [Full Text]

				I. Rogatsky, A. B. Hittelman, D. Pearce, and M. J. Garabedian Distinct Glucocorticoid Receptor Transcriptional Regulatory Surfaces Mediate the Cytotoxic and Cytostatic Effects of Glucocorticoids Mol. Cell. Biol., July 1, 1999; 19(7): 5036 - 5049. [Abstract] [Full Text] [PDF]

				D. Pennica, T. A. Swanson, J. W. Welsh, M. A. Roy, D. A. Lawrence, J. Lee, J. Brush, L. A. Taneyhill, B. Deuel, M. Lew, et al. WISP genes are members of the connective tissue growth factor family that are up-regulated in Wnt-1-transformed cells and aberrantly expressed in human colon tumors PNAS, December 8, 1998; 95(25): 14717 - 14722. [Abstract] [Full Text] [PDF]

				M. Friedrich, L. Rafi, W. Tilgen, W. Schmidt, and J. Reichrath Expression of 1,25-Dihydroxy Vitamin D3 Receptor in Breast Carcinoma J. Histochem. Cytochem., November 1, 1998; 46(11): 1335 - 1338. [Abstract] [Full Text]

				C. Collins, J. M. Rommens, D. Kowbel, T. Godfrey, M. Tanner, S.-i. Hwang, D. Polikoff, G. Nonet, J. Cochran, K. Myambo, et al. Positional cloning of ZNF217 and NABC1: Genes amplified at 20q13.2 and overexpressed in breast carcinoma PNAS, July 21, 1998; 95(15): 8703 - 8708. [Abstract] [Full Text] [PDF]

				O. Monni, M. Barlund, S. Mousses, J. Kononen, G. Sauter, M. Heiskanen, P. Paavola, K. Avela, Y. Chen, M. L. Bittner, et al. Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer PNAS, May 8, 2001; 98(10): 5711 - 5716. [Abstract] [Full Text] [PDF]